AI
Converge Bio Raises $25M, Backed by Bessemer and Executives From Meta, OpenAI, and Wiz
AI-driven drug discovery startup Converge Bio has raised a $25 million Series A round led by Bessemer Venture Partners to accelerate pharmaceutical research using generative models trained on molecular data.